Page last updated: 2024-11-02

pioglitazone and Postoperative Complications

pioglitazone has been researched along with Postoperative Complications in 3 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.

Research Excerpts

Excerpt	Relevance	Reference
"To examine the impact of a recent surgery on development of endometriosis-related adhesions in a chimeric model and to determine the therapeutic efficacy of pioglitazone (PIO)."	3.77	Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis. ( Bruner-Tran, KL; Camargos, AF; Carvalho-Macedo, AC; Crispens, MA; Herington, JL; Lebovic, DI; Osteen, KG, 2011)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Lo, C	1
Toyama, T	1
Oshima, M	1
Jun, M	1
Chin, KL	1
Hawley, CM	1
Zoungas, S	1
Zhang, Z	1
Yuan, H	1
Zhao, H	1
Qi, B	1
Li, F	1
An, L	1
Herington, JL	1
Crispens, MA	1
Carvalho-Macedo, AC	1
Camargos, AF	1
Lebovic, DI	1
Bruner-Tran, KL	1
Osteen, KG	1

Clinical Trials (12)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Efficacy and Safety of Empagliflozin Compared With Linagliptin in New-onset Diabetes Mellitus After Kidney Transplantation[NCT03642184]	Phase 4	6 participants (Actual)	Interventional	2018-07-14	Terminated (stopped due to Difficult in enrolling suitable participants)
Influence of Pioglitazone for Renal Transplant Function in Diabetics - a Double Blind Randomised Placebo Controlled Cross Over Study[NCT00507494]	Phase 3	0 participants	Interventional	2007-07-31	Completed
Treat-To-Target Trial of Continuous Subcutaneous, Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation (SAPT-NODAT)[NCT01680185]	Phase 3	85 participants (Actual)	Interventional	2012-08-31	Completed
A Randomized Controlled Trial of Pioglitazone on Insulin Resistance, Insulin Secretion and Atherosclerosis in Renal Allograft Recipients Without History of Diabetes[NCT00598013]		83 participants (Actual)	Interventional	2004-11-30	Completed
Vildagliptin in New Onset Diabetes After Transplantation - A Double-blind, Randomized, Placebo-controlled Trial[NCT00980356]	Phase 2	32 participants (Actual)	Interventional	2009-09-30	Completed
Intravenous Insulin Protocol in Diabetes and Renal Transplantation Study[NCT00609986]		104 participants (Actual)	Interventional	2007-07-31	Completed
The Effect of Sitagliptin Treatment on Glucose Metabolism and Endothelial Function in Renal Transplant Recipients - JANUVIA-08[NCT00740363]	Phase 4	25 participants (Actual)	Interventional	2008-09-30	Completed
Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia (TIP): Efficacy and Safety of a Novel Protocol in Renal Transplant Recipients Receiving a Tacrolimus-based Immunosuppression[NCT00830297]	Phase 2	50 participants (Actual)	Interventional	2009-01-31	Completed
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Post-transplantation Diabetes Mellitus[NCT03157414]	Phase 4	49 participants (Actual)	Interventional	2016-11-07	Completed
Randomized Controlled Trial Comparing the Metabolic Efficiency of Allogeneic Pancreatic Islet Transplantation to Intensive Insulin Therapy for the Treatment of Type 1 Diabetes[NCT01148680]	Phase 3	50 participants (Actual)	Interventional	2010-06-30	Completed
Glucose Control in Pre-Diabetic Renal Transplant Patients: Efficacy and Safety of Vildagliptin and Pioglitazone[NCT01346254]	Phase 2	51 participants (Actual)	Interventional	2009-12-31	Completed
Randomized Study of the Impact of Peri-operative Glucose Control on Short Term Renal Allograft Function After Transplantation[NCT01643382]		60 participants (Actual)	Interventional	2012-08-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Acute/Active Rejection

Grades IA through III and antibody immediate rejection, either A (immediate or hyperacute) or B (delayed or accelerated acute) were diagnosed and classified based on renal allograft biopsies according to the Banff 97 Working Classification of Renal Allograph Pathology. (NCT00609986)
Timeframe: 30 months

Intervention	participants (Number)
Intensive	9
Control	2

Delayed Graft Function

Need for dialysis in the first week post-transplant in a patient who required dialysis pre-transplantation or day-10 post-transplant creatinine concentration above 2.5 mg/dl. (NCT00609986)
Timeframe: 10 days

Intervention	participants (Number)
Intensive	8
Control	12

Severe Hyperglycemia

Blood glucose greater than 350 mg/dl. (NCT00609986)
Timeframe: 30 months

Intervention	participants (Number)
Intensive	5
Control	12

Severe Hypoglycemia

Blood glucose less than 40 mg/dl (NCT00609986)
Timeframe: 30 months

Intervention	participants (Number)
Intensive	7
Control	2

Incidence of Poor Graft Function After Kidney Transplant

Our primary endpoint will be poor initial graft function defined by the occurrence of DGF (defined by a decrease in serum creatinine of <10%/day for 3 consecutive days after transplant) or slow graft function (serum creatinine >3 mg/dL 5 days after transplant without dialysis) (NCT01643382)
Timeframe: 7 days after transplant

Intervention	Participants (Count of Participants)
Tight Glucose Control	13
Standard Glucose Control	22

Reviews

1 review available for pioglitazone and Postoperative Complications

Article	Year
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020

Other Studies

2 other studies available for pioglitazone and Postoperative Complications

Article	Year
PPARγ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice. International immunopharmacology, 2017, Volume: 43 Topics: Aging; Anilides; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cognitive Dysfunction;	2017
Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis. Fertility and sterility, 2011, Mar-15, Volume: 95, Issue:4 Topics: Animals; Disease Models, Animal; Endometriosis; Endometrium; Female; Humans; Mice; Mice, Nude; Piogl	2011